Discover open access scientific publications

Search, annotate, share and cite publications

Publications by J. Lue

Clinical and Biological Evaluation of the Novel Cd30/Cd16a Tetravalent Bispecific Antibody (Afm13) in Relapsed or Refractory Cd30-Positive Lymphoma With Cutaneous Presentation: A Biomarker Phase Ib/Iia Study (Nct03192202)

Hematological Oncology

English

Parametric Study of the Stability Margins of Cable-In-Conduit Superconductors: Experiment

IEEE Transactions on Magnetics

Electronic Engineering

English

Related publications

Targeted Drug Brentuximab Vedotin for Treatment of Relapsed or Refractory Cd30-Positive Hodgkin’s Lymphoma

Malignant tumours

2017

English

Brentuximab Vedotin for Relapsed or Refractory CD30+ Hodgkin Lymphoma: A Multicenter Analysis From Asia

OncoTargets and Therapy

Oncology

Pharmacology

2014

English

Final Data From the Phase 3 Alcanza Study: Brentuximab Vedotin (Bv) vs Physician's Choice (Pc) in Patients (Pts) With Cd30-Positive (Cd30+) Cutaneous T-Cell Lymphoma (Ctcl)

Hematological Oncology

English

Autologous T Cells Expressing CD30 Chimeric Antigen Receptors for Relapsed or Refractory Hodgkin's Lymphoma: An Open-Label Phase 1 Trial

The Lancet

Medicine

2015

English

CD30-CD30 Ligand Interaction in Primary Cutaneous CD30+T-Cell Lymphomas: A Clue to the Pathophysiology of Clinical Regression

English

Primary Cutaneous CD30+ Anaplastic Large Cell Lymphoma

Atlas of Genetics and Cytogenetics in Oncology and Haematology

English

Phase Ib/Ii Study of Ibrutinib and Venetoclax in Relapsed and Refractory Follicular Lymphoma

Hematological Oncology

English

A Phase Iia Study Evaluating the Safety and Tolerability of Umbralisib and Ibrutinib in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Hematological Oncology

English

Primary Cutaneous CD30-positive Large T-Cell Lymphoma With Secondary Lymph Node Involvement Detected by Sentinel Lymphonodectomy

Acta Dermato-Venereologica

Dermatology

Medicine

2002

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by J. Lue

Clinical and Biological Evaluation of the Novel Cd30/Cd16a Tetravalent Bispecific Antibody (Afm13) in Relapsed or Refractory Cd30-Positive Lymphoma With Cutaneous Presentation: A Biomarker Phase Ib/Iia Study (Nct03192202)

Parametric Study of the Stability Margins of Cable-In-Conduit Superconductors: Experiment

Related publications

Targeted Drug Brentuximab Vedotin for Treatment of Relapsed or Refractory Cd30-Positive Hodgkin’s Lymphoma

Brentuximab Vedotin for Relapsed or Refractory CD30+ Hodgkin Lymphoma: A Multicenter Analysis From Asia

Final Data From the Phase 3 Alcanza Study: Brentuximab Vedotin (Bv) vs Physician's Choice (Pc) in Patients (Pts) With Cd30-Positive (Cd30+) Cutaneous T-Cell Lymphoma (Ctcl)

Autologous T Cells Expressing CD30 Chimeric Antigen Receptors for Relapsed or Refractory Hodgkin's Lymphoma: An Open-Label Phase 1 Trial

CD30-CD30 Ligand Interaction in Primary Cutaneous CD30+T-Cell Lymphomas: A Clue to the Pathophysiology of Clinical Regression

Primary Cutaneous CD30+ Anaplastic Large Cell Lymphoma

Phase Ib/Ii Study of Ibrutinib and Venetoclax in Relapsed and Refractory Follicular Lymphoma

A Phase Iia Study Evaluating the Safety and Tolerability of Umbralisib and Ibrutinib in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Primary Cutaneous CD30-positive Large T-Cell Lymphoma With Secondary Lymph Node Involvement Detected by Sentinel Lymphonodectomy